Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $608.6 million.

  • Amphastar Pharmaceuticals' Non-Current Debt rose 203.47% to $608.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $608.6 million, marking a year-over-year increase of 203.47%. This contributed to the annual value of $601.6 million for FY2024, which is 204.4% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Non-Current Debt stood at $608.6 million for Q3 2025, which was up 203.47% from $607.7 million recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Non-Current Debt high stood at $638.2 million for Q3 2023, and its period low was $30.5 million during Q2 2021.
  • In the last 5 years, Amphastar Pharmaceuticals' Non-Current Debt had a median value of $488.3 million in 2023 and averaged $341.9 million.
  • Its Non-Current Debt has fluctuated over the past 5 years, first crashed by 1202.13% in 2021, then surged by 76231.24% in 2023.
  • Amphastar Pharmaceuticals' Non-Current Debt (Quarter) stood at $74.8 million in 2021, then decreased by 2.59% to $72.8 million in 2022, then soared by 709.43% to $589.6 million in 2023, then grew by 2.04% to $601.6 million in 2024, then rose by 1.16% to $608.6 million in 2025.
  • Its Non-Current Debt stands at $608.6 million for Q3 2025, versus $607.7 million for Q2 2025 and $603.9 million for Q1 2025.